$ESGH
ESG Inc.

2022 Q3 Form 10-Q Financial Statement

#000152013822000317 Filed on July 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $0.00 $30.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $65.00 $65.00
YoY Change
% of Gross Profit
Operating Expenses $0.00 $565.00 $28.09K
YoY Change
Operating Profit -$565.00 -$28.09K
YoY Change
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $0.00 -$556.00 -$28.07K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $0.00 -$556.00 -$28.07K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 15.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K $90.00K
YoY Change
Cash & Equivalents $86.14K $86.63K $87.12K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $86.14K $86.63K
YoY Change -37.85%
LONG-TERM ASSETS
Property, Plant & Equipment $1.029K $1.094K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.029K $1.094K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $86.14K $86.63K
Total Long-Term Assets $1.029K $1.094K
Total Assets $87.17K $87.72K
YoY Change -37.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.366K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.366K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.366K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.366K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$56.37K -$52.44K
YoY Change 3781.89%
Common Stock $15.47K $15.47K
YoY Change 0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $83.80K $87.72K $88.28K
YoY Change
Total Liabilities & Shareholders Equity $87.17K $87.72K
YoY Change -37.11%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $0.00 -$556.00 -$28.07K
YoY Change
Depreciation, Depletion And Amortization $0.00 $65.00 $65.00
YoY Change
Cash From Operating Activities $0.00 $0.00 -$30.00K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 0.000 0.000 -30.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000
Net Change In Cash 0.000 0.000 -30.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 -$30.00K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow $0.00 $0.00 -$30.00K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Liabilities
Liabilities
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Central Index Key
EntityCentralIndexKey
0001883835
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2021Q3 us-gaap Liabilities
Liabilities
usd
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-259772
dei Entity Registrant Name
EntityRegistrantName
PLASMA INNOVATIVE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1918342
dei Entity Address Address Line1
EntityAddressAddressLine1
523 School House Rd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Kennett Square
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19348
dei City Area Code
CityAreaCode
267
dei Local Phone Number
LocalPhoneNumber
467-5871
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15466668 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86630 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127604 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
86630 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
138604 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1094 usd
CY2022Q2 us-gaap Assets
Assets
87724 usd
CY2021Q3 us-gaap Assets
Assets
138604 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
15467 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
15356 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
124700 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52443 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1452 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
87724 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
138604 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87724 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138604 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
565 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51022 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
565 usd
us-gaap Operating Expenses
OperatingExpenses
51022 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-565 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-51022 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
9 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
31 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-556 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50991 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-556 usd
us-gaap Net Income Loss
NetIncomeLoss
-50991 usd
CY2022Q2 plasma Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
plasma Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2022Q2 plasma Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
15411729 shares
plasma Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
15411729 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50991 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
195 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39796 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1289 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1289 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127604 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86630 usd
us-gaap Stock Issued1
StockIssued1
111 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
138604 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-22368 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
116348 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112 usd
CY2022Q1 plasma Shares Issued For Intangible Assets
SharesIssuedForIntangibleAssets
111 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-28067 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
88280 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-556 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
87724 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zcm6ZPQL11o7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zRDEHwrC8f95">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Although these estimates are based on management’s knowledge of current events and actions management may undertake in the future, actual results may ultimately differ from those estimates and such differences may be material to our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p>
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86630 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1094 usd
CY2022Q2 us-gaap Depreciation
Depreciation
65 usd
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_847_eus-gaap--RevenueRecognitionDeferredRevenue_z5vSYZO5FBO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zAG7lGuDU1Fk">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will recognize revenue in accordance with ASC Topic 606 “Revenue Recognition”. The Company recognizes revenue when products are fully delivered, or services have been provided and collection is reasonably assured.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15466668 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15466668 shares

Files In Submission

Name View Source Status
0001520138-22-000317-index-headers.html Edgar Link pending
0001520138-22-000317-index.html Edgar Link pending
0001520138-22-000317.txt Edgar Link pending
0001520138-22-000317-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plas-20220531_10q.htm Edgar Link pending
plas-20220531_10qex31z1.htm Edgar Link pending
plas-20220531_10qex32z1.htm Edgar Link pending
plasma-20220531.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
plasma-20220531_cal.xml Edgar Link unprocessable
plasma-20220531_def.xml Edgar Link unprocessable
plasma-20220531_lab.xml Edgar Link unprocessable
plasma-20220531_pre.xml Edgar Link unprocessable
plas-20220531_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending